School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou University City, Guangzhou, PR China.
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou University City, Guangzhou, PR China; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, PR China.
Biochim Biophys Acta Gene Regul Mech. 2023 Jun;1866(2):194912. doi: 10.1016/j.bbagrm.2023.194912. Epub 2023 Feb 6.
c-Kit protein is a signal transduction protein involved in multiple signal pathways, which play an important role in a variety of cellular events such as cell proliferation, apoptosis and differentiation. Special DNA secondary structures on the promoter of c-Kit gene, including G-quadruplex and i-motif structures, could act as "molecular switch" for gene transcriptional regulation, which are potentially important target for development of new anti-cancer drugs.
We screened and evaluated the effect of compounds on c-Kit through several experiments, including SPR, FRET, CD, MST, NMR, dual-luciferase reporter assay, Western blot, qPCR, immunofluorescence, MTT assay, colony formation, cell scrape, cell apoptosis, cell cycle analysis, and transwell assay.
After extensive screening, we found that bisacridine derivative B05 had selective binding and stabilization to dual i-motif structures on c-Kit gene promoter, which could down-regulate c-Kit gene transcription and translation, resulting in inhibition of cell proliferation and metastasis. B05 exhibited potent anti-tumor activity on HGC-27 cells, and strongly suppressed tumor growth in HGC-27 xenograft mice model.
B05 could interact with c-Kit promoter dual i-motif structures with excellent selectivity, which make it possible for selective regulation of gene transcription and translation. B05 could be further developed for selective anti-cancer agent targeting c-Kit promoter i-motifs.
i-Motifs on different proto-oncogene promoters are diversified, and especially binding of dual i-motifs on the same promoter simultaneously could significantly down-regulate gene transcription with decreased dosage, and therefore increasing the selectivity. This new strategy shed bight light on development of selective DNA-targeting ligands.
c-Kit 蛋白是一种参与多种信号通路的信号转导蛋白,在细胞增殖、凋亡和分化等多种细胞事件中发挥重要作用。c-Kit 基因启动子上的特殊 DNA 二级结构,包括 G-四链体和 i- -motif 结构,可以作为基因转录调控的“分子开关”,是开发新型抗癌药物的潜在重要靶点。
我们通过 SPR、FRET、CD、MST、NMR、双荧光素酶报告基因检测、Western blot、qPCR、免疫荧光、MTT 检测、集落形成、细胞划痕、细胞凋亡、细胞周期分析和 Transwell 检测等实验筛选和评估了化合物对 c-Kit 的作用。
经过广泛筛选,我们发现双吖啶衍生物 B05 选择性结合并稳定 c-Kit 基因启动子上的双 i- motif 结构,从而下调 c-Kit 基因转录和翻译,抑制细胞增殖和转移。B05 对 HGC-27 细胞具有很强的抗肿瘤活性,并强烈抑制 HGC-27 异种移植小鼠模型中的肿瘤生长。
B05 可以与 c-Kit 启动子的双 i- motif 结构很好地相互作用,从而实现对基因转录和翻译的选择性调节。B05 可进一步开发为针对 c-Kit 启动子 i- motif 的选择性抗癌药物。
不同原癌基因启动子上的 i- motifs 多样化,特别是同一启动子上的双 i- motifs 同时结合可以显著下调基因转录,减少用量,从而提高选择性。这种新策略为开发选择性 DNA 靶向配体提供了新的思路。